PO.TB01.01 · 肿瘤生物学

腹水抵御铁死亡并促进卵巢癌的腹膜播散

Ascites protects against ferroptosis and enables the peritoneal spread of ovarian cancer

海报缩略图:腹水抵御铁死亡并促进卵巢癌的腹膜播散
编号 4803 展板 21 时间 4/21 09:00–12:00 区域 Section 25 主讲 Yasaman Setayeshpour, BS;MS
分会场 Angiogenesis
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Yasaman Setayeshpour1, Ssu-Yu Chen1, Divya L. Dayanidhi1, Yunji Lee1, Shao-Chin Wu1, Juan J. Aristizabal-Henao2, Jianli Wu1, Chao Chieh (Jerry) Lin1, Nazanin Setayeshpour1, Chiara Federico1, Alexander A. Mestre1, Michael A. Kiebish2, Andrew Berchuck1, David S. Hsu1, Zhiqing Huang1, Susan K. Murphy1, Jen-Tsan Ashley Chi1

1Duke University, Durham, NC,2BPGbio, Waltham, MA

摘要 Abstract

中文摘要
卵巢癌(OVCA)最常见的转移部位之一是腹膜。这种播散常伴随着腹腔内一种称为腹水的液体积聚。尽管腹水在转移性OVCA患者中常见,但对腹水及其对OVCA腹膜播散的影响知之甚少。有趣的是,OVCA细胞易发生铁死亡,这是一种由脂质氢过氧化物引起的细胞死亡类型。因此,这些对铁死亡敏感的OVCA细胞如何在向腹膜的播散中存活仍属未知。在此,我们发现腹水强有力地保护OVCA细胞系、患者来源肿瘤细胞和类器官免于铁死亡,并增强OVCA细胞在小鼠体内的腹膜播散。在机制上,腹水下调线粒体酶3-羟基-3-甲基戊二酰辅酶A合酶2(HMGCS2),从而促进脂滴增加。此外,在铁死亡诱导时,腹水抑制转铁蛋白受体TFRC的上调,从而降低细胞内不稳定铁水平。此外,我们发现降脂类贝特类药物可逆转腹水诱导的细胞变化,并减弱OVCA细胞在小鼠体内的腹膜播散。我们的发现揭示了腹水在铁死亡保护和OVCA腹膜播散中的重要性,并提示靶向腹水的铁死亡保护作用可能是限制OVCA转移的一种新的治疗方法。
查看英文原文 English abstract
One of the most common sites of metastasis in ovarian cancer (OVCA) is the peritoneum. Often, this spread is accompanied by the accumulation of a fluid called ascites in the peritoneal cavity. Despite its common occurrence in metastatic OVCA patients, ascites and its influence on the peritoneal spread of OVCA are poorly understood. Interestingly, OVCA cells are vulnerable to ferroptosis, a type of cell death caused by lipid hydroperoxides. Hence, how these ferroptosis-sensitive OVCA cells persist in their spread to the peritoneum remains unknown. Here, we show that ascites robustly protects OVCA cell lines, patient-derived tumor cells and organoids against ferroptosis and enhances the peritoneal spread of OVCA cells in mice. Mechanistically, ascites downregulates the mitochondrial enzyme, 3-hydroxy-3-methylglutaryl-CoA synthase 2 ( HMGCS2 ), which contributes to an increase in lipid droplets. Additionally, upon ferroptosis induction, ascites represses the upregulation of the transferrin receptor, TFRC , thereby decreasing cellular labile iron levels. Furthermore, we show that lipid-lowering fibrates reverse cellular changes induced by ascites, and they attenuate the peritoneal spread of OVCA cells in mice. Our findings implicate the importance of ascites in ferroptosis protection and the peritoneal spread of OVCA, and they suggest that targeting the ferroptosis protection by ascites may present a novel therapeutic approach to limit OVCA metastasis.
利益披露 Disclosure
Y. Setayeshpour, None.. S. Chen, None.. D. L. Dayanidhi, None.. Y. Lee, None.. S. Wu, None.. J. J. Aristizabal-Henao, None.. J. Wu, None.. N. Setayeshpour, None.. C. Federico, None.. A. A. Mestre, None.. M. A. Kiebish, None.. A. Berchuck, None.. D. S. Hsu, None.. Z. Huang, None.. S. K. Murphy, None.. J. A. Chi, None.

← 返回 AACR 2026 检索